Gary Kahing Yeung insider trades: Cero Therapeutics Holdings (CERO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gary reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | CERO | ↓ Sell | 5,957,250 | $0.07 | $400K | By YK Bioventures Opportunities Fund I, | Dec 13, 2024 (0d) |
| Dec 10, 2024 | CERO | ↓ Sell | 3,658,364 | $0.10 | $383K | By YK Bioventures Opportunities Fund I, | Dec 10, 2024 (0d) |
| Oct 10, 2024 | CERO | ↓ Sell | 3,250,000 | $0.10 | $325K | By YK Bioventures Opportunities Fund I, | Nov 14, 2024 (35d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gary Kahing Yeung's insider trades
Gary Kahing Yeung is a 10% owner of Cero Therapeutics Holdings (CERO). Since Oct 10, 2024, Gary has reported no open-market purchases and 3 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CERO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.